EBS vs MS · rev $1.04B vs P/E 20, $344.27B cap
Emergent Biosolutions Inc (EBS) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
MS does not have a complete income-statement cache yet.
EBS currently screens at market cap $416.4M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the EBS and MS stock pages for the full models.
Not investment advice.